title: Pioglitazone treatment in Cushing's disease.
authors.forename: D
authors.initials: D
authors.lastname: Barbaro
authors.forename: P
authors.initials: P
authors.lastname: Lapi
authors.forename: P
authors.initials: P
authors.lastname: Orsini
authors.forename: C
authors.initials: C
authors.lastname: Pasquini
authors.forename: S
authors.initials: S
authors.lastname: Ciaccio
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000097:blood; D000368:Aged; D015897:Comorbidity; D003920:Diabetes Mellitus; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D006973:Hypertension / Q000150:complications; D015228:Hypertriglyceridemia; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D000077205:Pioglitazone; D047748:Pituitary ACTH Hypersecretion / Q000150:complications / Q000188:drug therapy*; D045162:Thiazolidinediones / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone; D000077205:Pioglitazone